FLASH SPRING SALE: 50% Off Premium Subscription >> FLASH SPRING SALE: 50% Off Premium >>
$0.460
-0.0050 (-1.08%)
At Close: May 01, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $0.450 $0.570 Wednesday, 1st May 2024 NWBO stock ended at $0.460. This is 1.08% less than the trading day before Tuesday, 30th Apr 2024. During the day the stock fluctuated 5.56% from a day low at $0.450 to a day high of $0.475.
90 days $0.450 $0.650
52 weeks $0.400 $1.09

Historical Northwest Biotherapeutics prices

Date Open High Low Close Volume
May 01, 2024 $0.469 $0.475 $0.450 $0.460 1 740 860
Apr 30, 2024 $0.482 $0.482 $0.460 $0.465 993 823
Apr 29, 2024 $0.495 $0.522 $0.462 $0.473 1 326 354
Apr 26, 2024 $0.480 $0.490 $0.459 $0.485 1 493 803
Apr 25, 2024 $0.470 $0.487 $0.460 $0.477 1 098 120
Apr 24, 2024 $0.490 $0.504 $0.460 $0.460 1 170 694
Apr 23, 2024 $0.499 $0.500 $0.463 $0.472 1 867 962
Apr 22, 2024 $0.505 $0.512 $0.480 $0.480 1 499 476
Apr 19, 2024 $0.520 $0.520 $0.480 $0.480 1 678 149
Apr 18, 2024 $0.500 $0.519 $0.495 $0.510 1 123 818
Apr 17, 2024 $0.505 $0.524 $0.499 $0.501 1 248 372
Apr 16, 2024 $0.518 $0.523 $0.500 $0.506 1 182 627
Apr 15, 2024 $0.520 $0.540 $0.502 $0.502 1 067 559
Apr 12, 2024 $0.536 $0.540 $0.510 $0.520 873 055
Apr 11, 2024 $0.520 $0.540 $0.500 $0.516 1 646 684
Apr 10, 2024 $0.550 $0.560 $0.510 $0.518 1 934 391
Apr 09, 2024 $0.551 $0.569 $0.530 $0.530 865 390
Apr 08, 2024 $0.550 $0.570 $0.535 $0.537 772 401
Apr 05, 2024 $0.530 $0.550 $0.530 $0.542 927 409
Apr 04, 2024 $0.560 $0.565 $0.514 $0.545 2 307 802
Apr 03, 2024 $0.549 $0.560 $0.541 $0.550 1 512 222
Apr 02, 2024 $0.560 $0.560 $0.520 $0.547 987 460
Apr 01, 2024 $0.533 $0.562 $0.519 $0.521 2 546 287
Mar 28, 2024 $0.620 $0.620 $0.510 $0.519 4 217 677
Mar 27, 2024 $0.541 $0.649 $0.510 $0.600 3 959 506
Click to get the best stock tips daily for free!

About Northwest Biotherapeutics

Northwest Biotherapeutics Northwest Biotherapeutics, Inc., a biotechnology company, develops personalized immune therapies for cancer in the United States and internationally. The company develops its products based on DCVax, a platform technology that uses activated dendritic cells to mobilize a patient's own immune system to attack cancer. Its lead product, DCVax-L, which has completed Phase III clinical trials to treat Glioblastoma multiforme brain cancer. The company ... NWBO Profile

Golden Star

Ticker Date Change Price
ETSY Apr 26 1.84% $67.43
DHT Apr 24 1.24% $11.28
LPLA Apr 19 2.49% $262.59
MLI Apr 19 6.77% $52.28
PFLT Apr 18 1.07% $11.25
DOOR Apr 18 0.88% $131.39
LNG Apr 17 0.644% $156.81
FCN Apr 16 2.99% $207.62
ELV Apr 16 4.26% $506.97
ITCI Apr 05 4.92% $68.44
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT